Breaking News
BREAKING: DOJ Signs Cannabis into Schedule III
WASHINGTON – Today, the federal government took its most consequential ...
FDA Finalizes Psychedelic Drug Guidance and Schedules September Public Hearing
WASHINGTON, D.C., The US FDA has established clearer expectations for ...
Ascend Wellness Seeks Shareholder Approval for Reverse Stock Split Ahead of Potential Uplisting
NEW YORK – Ascend Wellness Holdings Inc., a vertically integrated ...
UN Approves WHO Recommendation On Rescheduling Medical Cannabis
In a move that could have a massive impact on marijuana reform efforts worldwide, the United Nations Commission on Narcotic Drugs (CND) has accepted a recommendation put forth by the World Health Organization (WHO) to ...
Lazear Advises Medical Cannabis Company Organic Remedies on ESOP Transaction
COLUMBUS, Ohio, July 6, 2026 – Organic Remedies, one of Pennsylvania's leading medical cannabis companies, has completed its transition to 100% employee ownership through an Employee Stock Ownership Plan (ESOP), marking another milestone in the ...
Q2 2026: The Quarter That Counted For Psychedelics
LOS ANGELES – Q2 2026 gave the psychedelic medicine sector the quarter that practitioners, investors, and regulators had been building up for years. Clinical programs delivered Phase 3 results, the White House signed an executive ...
California’s Legal Cannabis Market Holds Steady at Midyear
LOS ANGELES – California's licensed retailers generated $323.1 million in Cannabis sales in June, pushing the state's first-half total to nearly $1.95 billion. The June figure landed almost exactly in line with the roughly $322 ...
